Cargando…
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Doxorubicin is a commonly used chemotherapeutic agent for the treatment of a range of cancers, but despite its success in improving cancer survival rates, doxorubicin is cardiotoxic and can lead to congestive heart failure. Therapeutic options for this patient group are limited to standard heart fai...
Autores principales: | Timm, Kerstin N., Tyler, Damian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125062/ https://www.ncbi.nlm.nih.gov/pubmed/32034646 http://dx.doi.org/10.1007/s10557-020-06941-x |
Ejemplares similares
-
The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
por: Zilinyi, Rita, et al.
Publicado: (2018) -
Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity
por: Liu, Yihai, et al.
Publicado: (2021) -
The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
por: Syahputra, Rony Abdi, et al.
Publicado: (2022) -
Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity
por: Sergazy, Shynggys, et al.
Publicado: (2020) -
Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat
por: Baniahmad, Bahar, et al.
Publicado: (2020)